Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAndrew Sykes Regulatory News (ASY)

Share Price Information for Andrew Sykes (ASY)

Share Price is delayed by 15 minutes
Get Live Data
520.00    2.50 (0.48%)
Bid:
500.00
Ask:
540.00
Spread: 40.00 (8.00%)
Market Cap: £217.67m
ASY Live PriceLast checked at - London Stock Exchange

Intraday Andrew Sykes Share Chart

Director/PDMR Shareholding

4 Nov 2008 17:56

RNS Number : 4533H
Andrews Sykes Group PLC
04 November 2008
 

Andrews Sykes Group plc (the Company)

Director dealings

4 November 2008

The Company has been notified today that on 26 October 2008, the Chairman, Mr Jacques-Gaston Murray, transferred his controlling interest in the Tristar Corporation in equal proportion to two trusts; the Jean-Jacques Murray Trust and the Jean-Pierre Murray Trust.  Accordingly these two trusts are now the ultimate controlling parties of the Tristar Corporation and subsequently the ultimate controlling parties of the Company. 

The Tristar Corporation continues to control EOI Sykes Sarl which in turn has a beneficial interest in 36,377,213 ordinary shares of one pence each in the Company ("Ordinary Shares") representing approximately 82.17% of the Company's issued share capital. As a result of this transaction, the beneficial interest of Mr Jacques-Gaston Murray has decreased from 37,687,369 to 1,310,156 Ordinary Shares representing approximately 2.96% of the issued share capital of the Company.

For further information, please contact:

Andrews Sykes Group plc 01902 328700

Mark Calderbank

Brewin Dolphin Investment Banking

Andrew Kitchingman / Sean Wyndham-Quin 0845 270 8610

Ends

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSDZLFBVFBEFBB
Date   Source Headline
11th Mar 20212:00 pmRNSPrice Monitoring Extension
5th Mar 202111:28 amRNSBoard Appointment
28th Jan 20217:00 amRNSPaul Wood
18th Jan 20217:00 amRNSDirector leave of absence
17th Dec 20207:00 amRNSSenior Management Appointment
30th Sep 20207:00 amRNSHalf-year Report
24th Jul 20207:00 amRNSSpecial Dividend
17th Jun 202011:41 amRNSResult of AGM
20th May 20202:27 pmRNSAnnual Financial Report
12th May 20207:00 amRNSPreliminary results
27th Mar 20207:00 amRNSTrading update and impact of COVID-19
9th Mar 20202:05 pmRNSSecond Price Monitoring Extn
9th Mar 20202:00 pmRNSPrice Monitoring Extension
14th Jan 20203:40 pmRNSManagement Change
27th Sep 20197:00 amRNSHalf-year Report
29th Aug 20197:00 amRNSHolding(s) in Company
10th May 20197:00 amRNSFinal Results
8th Feb 201912:33 pmRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSUpdate on Remuneration Committee
28th Sep 20187:00 amRNSInterim Financial Statements 2018
10th Jul 201811:50 amRNSBoard Appointment
20th Jun 20181:14 pmRNSResult of AGM
1st Jun 20187:00 amRNSTransaction in Own Shares
25th May 20187:00 amRNSPosting of Annual Report
18th May 20187:00 amRNSPreliminary Results
7th Mar 20187:00 amRNSMichael Gailer
6th Dec 201710:53 amRNSDirector Shareholding
28th Sep 20179:28 amRNSHalf-year Report
23rd Aug 20177:00 amRNSDirector/PDMR Shareholding
11th May 20177:00 amRNSFinal Results
29th Sep 20167:00 amRNSHalf-year Report
1st Aug 20167:00 amRNSChange of name of NOMAD
11th May 20167:00 amRNSPreliminary Results
3rd Nov 20152:48 pmRNSChange of Registered Office
30th Sep 20157:00 amRNSHalf Yearly Report
17th Jun 20153:59 pmRNSChange of Registered Office
6th May 20157:01 amRNSFinal Results
2nd Mar 201512:13 pmRNSManagement Change
30th Dec 20145:52 pmRNSDirectorate Change
26th Sep 20147:00 amRNSHalf Yearly Report
7th May 20147:00 amRNSFinal Results
3rd Jan 20144:05 pmRNSDirector/PDMR Shareholding
29th Oct 20137:00 amRNSDividend Declaration
27th Sep 20137:00 amRNSHalf Yearly Report
8th Aug 20137:00 amRNSChange of Adviser
18th Jun 20132:05 pmRNSDividend Declaration
1st May 20137:00 amRNSFinal Results
30th Oct 20127:45 amRNSDividend Declaration
26th Sep 20127:00 amRNSHalf Yearly Report
12th Sep 20123:19 pmRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.